A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: Final analysis

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 1, 1997, Pages 163-168

  Bardet, Etienne ^a   Rivière, Alain ^b   Charloux, Anne ^b   Spaeth, Dominique ^b   Ducoloné, Alain ^b   Groumellec, Alain Le ^b   Pellae Cosset, Brigitte ^b   Henry Amar, Michel ^b   Douillard, Jean Yves ^b  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b NONE

Author keywords

Carboplatin; Irradiation; Nonsmall cell lung cancer

Indexed keywords

CARBOPLATIN; ETOPOSIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INOPERABLE CANCER; INTRAVENOUS DRUG ADMINISTRATION; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REMISSION INDUCTION; TREATMENT FAILURE;

EID: 0031128393     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00254-X     Document Type: Article

References (23)

1. 1. Arriagada, R.; Le Chevalier, T.; Quoix, E.; Ruffié, P.; De Cremoux, H.; Douillard, J. Y.; Tarayre, M.; Pignon, J. P.; Laplanche, A. ASTRO plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients. Int. J. Radiat. Oncol. Biol. Phys. 20:977-981; 1991.
2. 2. Blanke, C.; Ansari, R.; Mantravadi, R.; Gonin, R.; Tokars, R.; Fischer, W.; Pennington, K.; O'connor, T.; Rynard, S.; Miller, M.; Einhorn, L. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group Protocol. J. Clin. Oncol. 13:1425-1429; 1995.
3. 3. Bonomi, P. Carboplatin in non-small cell lung cancer: Review of the Eastern Cooperative Oncology Group trial and comparison with other carboplatin trials. Semin. Oncol. 18(Suppl. 2):2-7; 1991.
4. 4. Coughlin, C. T.; Richmond, R. C. Biologic and clinical developments of cisplatin combined with radiation: Concepts, utility, projections for new trials, and the emergence of carboplatin. Semin. Oncol. 16(Suppl. 6):31-43; 1989.
5. 5. Cox, J. D.; Pajak, T. F.; Asbell, S.; Russel, A. H.; Pedersen, J.; Byhardt, R. W.; Enami B.; Roach, M. Interruption of high-dose radiation therapy decrase long-term survival of favorable patients with unresectable non small cell carcinoma of the lung: Analysis of 1244 cases from three Radiation Therapy Oncology Group (RTOG) trials. Int. J. Radiat. Oncol. Biol. Phys. 27:493-498; 1993.
6. 6. Curran, W. J.; Scott, C. B.; Komaki, R.; Byhardt, R. W.; Taylor, S.; Emami, B.; Langer, C. J.; Dar, A. R.; Cooper, J. S.; Andras, E. J.; Sause, W. T. Response to induction chemotherapy does no predict for long term survival among patients with unresected stage III non-small cell lung cancer receiving sequential chemo-radiation on RTOG 88-04 and 88-08. Int. J. Radiat. Oncol. Biol. Phys. 32(Suppl. 1); 1995.
7. 7. Dillman, R. O.; Seagren, S. L.; Propert, K. J.; Guerra, J.; Eaton, W. L.; Perry, M. C.; Carey, R. W.; Frei, E. F.; Green, M. R. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N. Engl. J. Med. 4:940-945; 1990.
8. 8. Douple, E. B.; Richmond, R. C.; O'hara, J. A.; Coughlin, C. T. Carboplatin as a potentiator of radiation therapy. Cancer Treat. Rev. 12:111-124; 1985.
9. 9. Green, M. R. Chemotherapy and radiation in the nonoperative management of stage III non-small-cell lung cancer: The right chemotherapy works in the right setting. In: DeVita V. T., Hellman, S., Rosenberg, S. A., Steven, A., eds. Important advances in oncology. Philadelphia, PA: Lippincott Co.; 1993:125-137.
10. 10. Gregor, A.; Macbeth, F. R.; Paul, J.; Cram, L.; Hansen, H. H. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell-lung cancer: A randomized trial. J. Natl. Cancer Inst. 85:997-999; 1993.
11. 11. Holsti, L. R.; Mattson, K. A randomized study of split-course radiotherapy of lung cancer: Long term results. Int. J. Radiat. Oncol. Biol. Phys. 6:977-981; 1980.
12. 12. Klastersky, J.; Sculier, J. P.; Lacroix, H.; Dabouis, G.; Bureau, G.; Libert, P.; Richez, M.; Ravez, P.; Vandermonten, G.; Thiriaux, J.; Cordier, R.; Finet, C.; Berchier, M. C.; Sergysels, R.; Mommen, P.; Paesmans, M.; for the European Organization for Research and Treatment of Cancer Lung Cancer Working party. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell-lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J. Clin. Oncol. 8:1556-1562; 1990.
13. 13. Le Chevalier, T.; Amagada, R.; Quoix, E.; Ruffié, P.; Martin, M.; Tarayre, M.; Lacombe-Terrier, M. J.; Douillard, J. Y.; Laplanche, A. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J. Natl. Cancer Inst. 83:417-423; 1991.
14. 14. Mountain, C. F. A new international staging system for lung cancer. Chest 89:225-233; 1986.
15. 15. Perez, C. A.; Pajak, T. F.; Rubin, P.; Simpson, J. R.; Mohiuddin, M.; Brady, L. W.; Perez-Tamayo, R.; Rotman, M. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 59:1874-1881; 1987.
16. 16. Perez, C. A.; Stanley, K.; Grundy, G.; Hanson, W.; Rubin, P.; Kramer, S.; Brady, L. W.; Marks, J. E.; Perez-Tamayo, R.; Brown, S.; Concannon, J. P.; Rotman, M. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 50:1091-1099; 1982.
17. 17. Rothman, K. J.; Boice, J. D. Epidemiologic analysis with a programmable calculator. Boston, MA: Epidemiologic Resources Inc; 1982.
18. 18. Sause, W. T.; Scott, C.; Taylor, S.; Byhardt, R. W.; Banker, F. L.; Thomson, J. W.; Jones, T. K.; Cooper, J. S.; Lindberg, R. D. Phase II trial of combination chemotherapy and irradiation in non-small cell lung cancer, Radiation Therapy Oncology Group 88-04. Am. J. Clin. Oncol. 15:163-167; 1992.
19. 19. Schaake-Koning, C.; Van Den Bogaert, W.; Dalesio, O.; Festen, J.; Hoogenhout, J.; Van Houtte, P.; Kirkpatrick, A.; Koolen, M.; Maat, B.; Nijs, A.; Renaud, A.; Rodrigus, P.; Schuster-Uitterhoeve, L.; Sculier, J. P.; Van Zandwijk, N.; Bartelink, H. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell-lung cancer. N. Engl. J. Med. 326:524-530; 1992.
20. 20. Soresi, E.; Clerici, M.; Grilli, R.; Borghini, U.; Zucali, R.; Leoni, M.; Botturi, M.; Vergari, C.; Luporinni, G.; Scoccia, S. A randomized clinical trial comparing radiation therapy vs radiation therapy plus Cis-Dichlorodiamino Platinum (II) in the treatment of locally advanced non-small-cell-lung cancer. Semin. Oncol. 15(Suppl. 7):20-25; 1988.
21. 21. Trovo, M. G.; Minatel, E.; Franchin, G.; Boccieri, M. G.; Nascimben, O.; Bolzicco, G.; Pizzi, G.; Torreta, A.; Veronesi, A.; Gobitti, C.; Zanelli, D. J.; Monfardini, S. Radiotherapy vs radiotherapy enhanced by cisplatin in stage III non small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 24:11-15; 1992.
22. 22. Van Der Vijgh, W. J. F. Clinical pharmacokinetics of carboplatin. Clin. Pharmacokinet. 21:242-261; 1991.
23. 23. Yang, L. X.; Douple, E. B.; Wang, H. J. Irradiation enhances cellular uptake of carboplatin. Int. J. Radiat. Oncol. Biol. Phys. 33:641-646; 1995.